https://www.selleckchem.com/pr....oducts/8-cyclopentyl
In addition, the older-aged group showed lower HSUV and physical function. SPPB (β = 0.38, p 0.01), BFI (β = - 0.58, p 0.01), and MNA-SF (β = 0.29, p = 0.02) were independent factors affecting HSUV (adjusted R = 0.65, p 0.01). BFI was correlated with HSUV in both older and middle-aged groups. Comprehensive supports, to improve lower extremity function, fatigue, and nutritional status, are required to augment QoL and HSUV in patients with hematological malignancies. Comprehensive supports, to i